Aura Biosciences (AURA) Earnings Date & Reports

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AURA is expected to report earnings to fall 7.81% to -47 cents per share on May 08

Aura Biosciences AURA Stock Earnings Reports

Q1'25

Est.

$-0.48

Q4'24

Missed

by $0.08

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.04

The last earnings report on March 24 showed earnings per share of -51 cents, missing the estimate of -43 cents. With 3.12M shares outstanding, the current market capitalization sits at 318.43M.

View a ticker or compare two or three

Compare

AURA